REPORTS on glucose utilization in depressive illness, as measured by the intravenous glucose tolerance test (GTT), are in conflict. In 1958 pryce1,2 reported that depressed patients had lower glucose utilization rates (k) than normal subjects. This lowered k was not related to loss of body weight, and it did not change significantly following successful treatment with electroconvulsive therapy (ECT). Herzberg et al in 19683 reported, however, no clear association between depression and lowered oral or intravenous GTT. These authors reported no significant change in glucose utilization rate following recovery whether ECT, tryptophan, or no somatic treatment was employed. They attributed previously reported positive findings of the GTT in depression to either malnutrition or inactivity. Pryce's data were more consistent with the report by Van Praag and Leijnse in 19654 6 where decreased glucose utilization, as measured by forearm arteriovenous glucose difference, was associated with depressive illness.
Mueller PS, Heninger GR, McDonald RK. Intravenous Glucose Tolerance Test in Depression. Arch Gen Psychiatry. 1969;21(4):470–477. doi:10.1001/archpsyc.1969.01740220086010
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.